Organigram Global Inc. (TSX:OGI)
Canada · Delayed Price · Currency is CAD 1.390
+0.020 (1.46%)
Aug 10, 2026, 11:29 AM EST
Organigram Global Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 274.19 | 259.18 | 159.84 | 149.21 | 145.81 | 79.16 | |
Revenue Growth | 41.27% | 62.15% | 7.13% | 2.33% | 84.19% | -8.79% |
Cost of Revenue | 176.48 | 168.97 | 112.32 | 114.13 | 114.24 | 107.56 |
Gross Profit | 97.71 | 90.22 | 47.52 | 35.07 | 31.57 | -28.4 |
Selling, General & Admin | 98.62 | 90.6 | 64.81 | 66.81 | 64.51 | 48.94 |
Research & Development | 10.02 | 10.95 | 11.2 | 12.19 | 5.96 | 3.65 |
Operating Expenses | 111.83 | 105.52 | 82.28 | 83.86 | 70.48 | 52.59 |
Operating Income | -14.13 | -15.3 | -34.76 | -48.79 | -38.91 | -80.99 |
Interest Expense | - | - | - | - | -0.43 | -2.96 |
Interest & Investment Income | 0.55 | 1.15 | 3.31 | 3.41 | 1.49 | 0.85 |
Earnings From Equity Investments | - | - | -5.28 | -0.93 | -1.36 | -1.12 |
Other Non Operating Income (Expenses) | -3.64 | -0.03 | -0.76 | 4.54 | 32.65 | -29.83 |
EBT Excluding Unusual Items | -17.22 | -14.18 | -37.49 | -41.77 | -6.56 | -114.04 |
Merger & Restructuring Charges | -7.06 | -6.58 | -0.92 | - | - | - |
Impairment of Goodwill | - | - | - | -38.75 | - | - |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.63 | -0.39 | -6.58 | -2.43 |
Asset Writedown | -5.8 | - | - | -155.2 | -4.25 | -10.83 |
Legal Settlements | - | - | - | - | 0.31 | -2.75 |
Other Unusual Items | -8.79 | -17.76 | -7.67 | 3.11 | 2.53 | -0.66 |
Pretax Income | -38.87 | -38.53 | -45.44 | -233 | -14.37 | -130.7 |
Income Tax Expense | -13.66 | -13.77 | - | -3.52 | -0.09 | - |
Earnings From Continuing Operations | -25.21 | -24.76 | -45.44 | -229.48 | -14.28 | -130.7 |
Net Income | -25.21 | -24.76 | -45.44 | -229.48 | -14.28 | -130.7 |
Net Income to Common | -25.21 | -24.76 | -45.44 | -229.48 | -14.28 | -130.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 135 | 128 | 95 | 81 | 77 | 64 |
Shares Outstanding (Diluted) | 135 | 128 | 95 | 81 | 77 | 64 |
Shares Change | 16.99% | 33.98% | 17.22% | 5.26% | 20.61% | 48.33% |
EPS (Basic) | -0.19 | -0.19 | -0.48 | -2.82 | -0.18 | -2.04 |
EPS (Diluted) | -0.19 | -0.19 | -0.48 | -2.82 | -0.18 | -2.04 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -20.81 | -24.61 | -0.86 | -62.7 | -84.96 | -40.35 |
Free Cash Flow Per Share | -0.15 | -0.19 | -0.01 | -0.77 | -1.10 | -0.63 |
Gross Margin | 35.63% | 34.81% | 29.73% | 23.51% | 21.65% | -35.87% |
Operating Margin | -5.15% | -5.90% | -21.74% | -32.70% | -26.68% | -102.30% |
Profit Margin | -9.20% | -9.55% | -28.43% | -153.80% | -9.80% | -165.11% |
Free Cash Flow Margin | -7.59% | -9.50% | -0.54% | -42.02% | -58.27% | -50.97% |
EBITDA | 3.05 | 0.76 | -23.04 | -25.37 | -15.06 | -50.92 |
EBITDA Margin | 1.11% | 0.29% | -14.41% | -17.00% | -10.32% | -64.33% |
D&A For EBITDA | 17.17 | 16.06 | 11.72 | 23.42 | 23.85 | 30.06 |
EBIT | -14.13 | -15.3 | -34.76 | -48.79 | -38.91 | -80.99 |
EBIT Margin | -5.15% | -5.90% | -21.74% | -32.70% | -26.68% | -102.30% |
Revenue as Reported | 274.19 | 259.18 | 159.84 | 149.21 | 145.81 | 79.16 |